Medication-Assisted Treatment (MAT) in Wayne, PA
Medication-Assisted Treatment (MAT) is the evidence-based use of FDA-approved medications combined with counseling and behavioral therapies to treat substance use disorders. For opioid use disorder and alcohol use disorder in particular, MAT is recognized by the Substance Abuse and Mental Health Services Administration (SAMHSA) as the gold standard of care — producing significantly better outcomes than either medication or therapy alone.
Provive Wellness in Wayne, PA integrates MAT into our PHP and IOP programs for adults throughout the Philadelphia Main Line, Chester County, Delaware County, and Montgomery County. If you or someone you love is struggling with opioid or alcohol dependence, MAT may be an important part of an effective, lasting recovery. Call (610) 947-0800 to speak with our admissions team.
Key Takeaways
- MAT combines FDA-approved medications with counseling and behavioral therapies to treat opioid use disorder and alcohol use disorder.
- SAMHSA identifies MAT as the gold standard of care for opioid use disorder, significantly reducing cravings, withdrawal symptoms, and overdose risk.
- MAT is not “trading one addiction for another” — this is a harmful and inaccurate misconception. FDA-approved MAT medications are prescribed and monitored by licensed clinicians as part of a comprehensive treatment plan.
- Provive Wellness in Wayne, PA integrates MAT into PHP and IOP programs, serving adults throughout the Philadelphia Main Line, Chester County, Delaware County, and Montgomery County.
- Most major insurance plans cover MAT. Call (610) 947-0800 to verify your benefits. Same-week appointments are often available.
Table of Contents
- What Is Medication-Assisted Treatment (MAT)?
- How MAT Works
- FDA-Approved Medications Used in MAT
- MAT for Opioid Use Disorder
- MAT for Alcohol Use Disorder
- Common Misconceptions About MAT
- MAT at Provive Wellness in Wayne, PA
- Levels of Care Alongside MAT at Provive
- Does Insurance Cover MAT in Pennsylvania?
- Frequently Asked Questions
- Getting Started
What Is Medication-Assisted Treatment (MAT)?
Medication-Assisted Treatment is an approach to addiction treatment that uses FDA-approved medications — alongside individual therapy, group therapy, and structured clinical support — to address the physical and psychological dimensions of substance use disorders simultaneously.
MAT is not a standalone solution. The medications used in MAT reduce cravings, manage withdrawal symptoms, and block the rewarding effects of drugs and alcohol — creating the neurological space in which behavioral therapy can be most effective. According to the National Institute of Mental Health (NIMH), combined pharmacological and behavioral treatment produces better outcomes for most substance use disorders than either approach alone.
MAT is approved by the FDA, endorsed by SAMHSA, and recommended by every major medical authority — including the American Psychiatric Association and the American Psychological Association — as a core component of effective addiction treatment.
How MAT Works
Substance use disorders involve changes in brain chemistry — particularly in the dopamine and opioid receptor systems — that make stopping difficult even when a person is highly motivated to recover. Cravings, withdrawal symptoms, and the conditioned responses built up over years of use are neurobiological phenomena, not character flaws.
MAT medications work by targeting these neurobiological mechanisms directly:
- Agonist medications (such as buprenorphine) activate the same receptors as opioids but in a controlled, partial way — reducing withdrawal and cravings without producing the intense euphoria of illicit opioids.
- Antagonist medications (such as naltrexone) block opioid and alcohol receptors entirely — eliminating the rewarding effects of use and reducing the drive to drink or use.
- Aversion medications (such as disulfiram) create an unpleasant physical reaction to alcohol consumption — providing a deterrent effect that supports abstinence.
When combined with structured psychotherapy in a program like PHP or IOP, these medications give clients the neurological stability to engage meaningfully in treatment, build coping skills, and work toward lasting recovery.
FDA-Approved Medications Used in MAT
For Opioid Use Disorder
Buprenorphine (Suboxone, Subutex, Sublocade): A partial opioid agonist that reduces withdrawal symptoms and cravings without producing significant euphoria at therapeutic doses. Suboxone combines buprenorphine with naloxone to deter misuse. Buprenorphine can be prescribed by licensed providers in outpatient settings, making it well-suited to integration with PHP and IOP.
Naltrexone (Vivitrol): An opioid antagonist that blocks opioid receptors entirely, preventing opioids from producing their rewarding effects. Available as a once-monthly injectable (Vivitrol) or daily oral tablet. Naltrexone requires a period of abstinence from opioids before initiation to avoid precipitated withdrawal.
For Alcohol Use Disorder
Naltrexone (oral or Vivitrol): Also FDA-approved for alcohol use disorder, naltrexone reduces the rewarding effects of alcohol and decreases the urge to drink. It is one of the most commonly prescribed MAT medications for AUD in outpatient settings.
Acamprosate (Campral): Reduces the anxiety, insomnia, and restlessness associated with protracted alcohol withdrawal and early abstinence — making the early recovery period more tolerable and reducing relapse risk.
Disulfiram (Antabuse): Causes an unpleasant physical reaction — flushing, nausea, palpitations — when alcohol is consumed, providing a behavioral deterrent to drinking. Most effective when taken under supervision.
MAT for Opioid Use Disorder
Opioid use disorder — including heroin, fentanyl, prescription opioids, and oxycodone dependence — is one of the most physically and psychologically demanding conditions to treat. The opioid epidemic continues to affect communities throughout Chester County, Delaware County, Montgomery County, and the broader Philadelphia region.
Without MAT, opioid withdrawal is an intensely uncomfortable experience that drives many people back to use before they can engage meaningfully in therapy. With buprenorphine or naltrexone, withdrawal is managed and cravings are reduced — creating the conditions for genuine clinical work. SAMHSA’s research consistently shows that MAT for opioid use disorder reduces illicit drug use, decreases overdose risk, lowers criminal activity, and improves treatment retention. See our guide to opioid and fentanyl addiction treatment in Wayne, PA.
Important note on medical detox: If you are currently using opioids daily and are physically dependent, medically supervised detoxification may be required before outpatient MAT can begin. Provive Wellness does not provide inpatient medical detox. If detox is needed, our admissions team will refer you to an appropriate medical detox facility and coordinate your step-down into PHP or IOP at Provive once you are medically stable.
MAT for Alcohol Use Disorder
Alcohol use disorder is the most prevalent substance use disorder in Pennsylvania and across the United States. While alcohol withdrawal can be medically serious and requires supervised detox for individuals with severe physical dependence, MAT for alcohol use disorder — particularly with naltrexone or acamprosate — is highly effective in the outpatient setting once medical stability is established.
Naltrexone has the strongest evidence base for reducing alcohol cravings and relapse in early recovery. The National Alliance on Mental Illness (NAMI) and HHS both identify medication as an underutilized but effective component of alcohol use disorder treatment. At Provive, MAT for AUD is integrated with individual therapy, group therapy, and relapse prevention planning within our PHP and IOP structure. See our guide to alcohol addiction treatment in Wayne, PA.
Common Misconceptions About MAT
“MAT is just trading one addiction for another.” This is the most common misconception about MAT — and the most harmful. FDA-approved MAT medications are prescribed and monitored by licensed medical providers as part of a comprehensive, evidence-based treatment plan. When used as directed, buprenorphine and naltrexone do not produce the euphoria, intoxication, or compulsive use that characterize addiction. SAMHSA, the American Psychiatric Association, and every major medical authority reject this framing as inaccurate and clinically harmful.
“People on MAT aren’t really in recovery.” Recovery is defined by a return to health, functioning, and the ability to live a meaningful life — not by the absence of medication. Millions of people use medication to manage chronic conditions including diabetes, hypertension, and depression. Using medication to manage a chronic brain disorder like opioid use disorder is no different. SAMHSA’s definition of recovery explicitly includes medication as a valid component of a recovery pathway.
“MAT is a permanent crutch.” The duration of MAT is determined by each individual’s clinical needs, in collaboration with their prescriber. Some people use MAT for months; others use it for years. Both are valid. The goal is stability, functioning, and quality of life — not meeting an arbitrary timeline.
MAT at Provive Wellness in Wayne, PA
Provive Wellness integrates MAT into our PHP and IOP programs at our Wayne, PA location at 489 Devon Park Dr, Wayne, PA 19087. Our psychiatric team conducts MAT evaluations, manages prescriptions, and monitors medication response as part of the treatment plan — alongside individual therapy, group programming, and holistic care.
MAT is not appropriate for every person in treatment, and Provive’s clinical team makes individualized recommendations based on each client’s diagnosis, history, and clinical needs. If MAT is recommended, prescribing and monitoring occur within the same program — not as a separate service requiring separate appointments.
Levels of Care Alongside MAT at Provive
PHP (Partial Hospitalization Program)
PHP provides 20 or more hours of structured clinical programming per week across 5–7 days for 4–6 weeks. For individuals beginning MAT, the intensive structure of PHP provides close clinical oversight during medication initiation and dose stabilization — the period when support is most critical. Learn more about PHP at Provive.
IOP (Intensive Outpatient Program)
IOP provides structured treatment across 3–6 days per week for 8–12 weeks. IOP allows clients to maintain work, school, and family responsibilities while continuing MAT and building the coping skills needed for sustained recovery. Learn more about IOP at our Wayne, PA location.
Does Insurance Cover MAT in Pennsylvania?
Yes. Under the Mental Health Parity and Addiction Equity Act (MHPAEA) and the Affordable Care Act (ACA), most insurance plans are required to cover MAT as part of substance use disorder treatment. This includes both the medications themselves and the associated clinical services (evaluation, prescribing, monitoring, therapy).
The U.S. Department of Health and Human Services has identified expanding access to MAT as a federal priority, and Pennsylvania has made significant state-level investments in reducing barriers to MAT access. Provive Wellness in Wayne, PA accepts:
- Aetna
- BlueCross BlueShield
- Cigna
- Independence Blue Cross
- Humana
- Anthem
- Magellan Health
- TRICARE
- VA Community Care Network (CCN)
- United Healthcare
- Optum
Call (610) 947-0800 and our admissions team will verify your benefits before your first appointment — at no cost to you.
Frequently Asked Questions
Is MAT right for everyone with opioid use disorder?
MAT is appropriate for most people with moderate to severe opioid use disorder, and SAMHSA recommends that it be offered to all eligible individuals. It is not a one-size-fits-all approach — Provive’s clinical and psychiatric team evaluates each person individually to determine whether MAT is appropriate, and which medication is the best fit based on their history, health status, and recovery goals.
Does Provive prescribe Suboxone / buprenorphine?
Provive’s psychiatric team includes licensed providers with the DEA waiver required to prescribe buprenorphine (Suboxone). Buprenorphine prescribing and monitoring occur within our PHP and IOP programs — integrated into the overall treatment plan rather than offered as a standalone service.
Can I start MAT without going through detox first?
For buprenorphine (Suboxone), initiation requires that you be in mild-to-moderate withdrawal before the first dose — but does not require a formal inpatient detox program. For naltrexone (Vivitrol), a period of abstinence is required before initiation to avoid precipitated withdrawal. If you are currently using opioids daily, our admissions team will discuss the right approach for your situation when you call.
How long does MAT last?
The duration of MAT is individualized. Clinical guidelines from SAMHSA and the American Society of Addiction Medicine do not specify a required duration — the evidence supports continued MAT for as long as it is clinically beneficial. Many people use MAT for one to two years; others use it longer. The decision is made collaboratively with your prescriber based on your progress, stability, and recovery goals.
Is MAT covered by Independence Blue Cross (IBX) in Pennsylvania?
Yes. Independence Blue Cross is required under MHPAEA to cover substance use disorder treatment including MAT. IBX covers both the medications and the associated clinical services when medically necessary. Provive accepts IBX and verifies your specific plan’s coverage before your first appointment. See our IBX coverage guide for more information.
What if I need alcohol detox before starting MAT at Provive?
Alcohol withdrawal can be medically serious. If you are physically dependent on alcohol, medically supervised detox is required before beginning outpatient treatment. Provive Wellness does not provide inpatient medical detox — our admissions team will refer you to an appropriate medical detox facility in the Wayne area and coordinate your step-down into PHP or IOP at Provive once you are medically stable.
Getting Started
Provive Wellness is located at 489 Devon Park Dr, Wayne, PA 19087, serving adults throughout the Philadelphia Main Line, Chester County, Delaware County, Montgomery County, and greater Philadelphia. Same-week appointments are often available.
If you are in crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline, available 24/7. The SAMHSA National Helpline (1-800-662-4357) provides free, confidential guidance on finding treatment.
Call (610) 947-0800 or contact us online to speak with our admissions team, verify your insurance, and find out how MAT can be part of your recovery plan.
